Global Dermatological Drugs Market 2018-2022

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

• Market ecosystem

• Market characteristics

• Market segmentation analysis

PART 05: PIPELINE ANALYSIS

• Pipeline analysis

PART 06: MARKET SIZING

• Market definition

• Market sizing 2017

• Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

• Bargaining power of buyers

• Bargaining power of suppliers

• Threat of new entrants

• Threat of substitutes

• Threat of rivalry

• Market condition

PART 08: MARKET SEGMENTATION BY APPLICATION

• Segmentation by application

• Eczema

• Psoriasis

• Acne

• Skin infections

• Others

PART 09: MARKET SEGMENTATION BY PRODUCT

• Segmentation by product

• Comparison by product

• Biologics – Market size and forecast 2017-2022

• Small molecules – Market size and forecast 2017-2022

• Market opportunity by product

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

• Geographical segmentation

• Regional comparison

• Americas – Market size and forecast 2017-2022

• EMEA – Market size and forecast 2017-2022

• APAC – Market size and forecast 2017-2022

• Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

• Market drivers

• Market challenges

PART 14: MARKET TRENDS

• Increase in prices of dermatological drugs

• Patent expiry of major drugs

• Availability of biologics/biosimilars for treatment

• Increasing research on gene therapy

PART 15: VENDOR LANDSCAPE

• Overview

• Landscape disruption

PART 16: VENDOR ANALYSIS

• Vendors covered

• Vendor classification

• Market positioning of vendors

• AbbVie

• Offering

• Description

• Amgen

• Celgene

• Johnson & Johnson

PART 17: APPENDIX

• List of abbreviations

Exhibit 01: Parent market

Exhibit 02: Global pharmaceutical drugs market

Exhibit 03: Market characteristics

Exhibit 04: Market segments

Exhibit 05: Potential phase III agents for eczema, psoriasis, acne, and skin infection

Exhibit 06: Market definition - Inclusions and exclusions checklist

Exhibit 07: Market size 2017

Exhibit 08: Validation techniques employed for market sizing 2017

Exhibit 09: Global dermatological drugs market – Market size and forecast 2017-2022 ($ bn)

Exhibit 10: Global dermatological drugs market – Year over year growth 2018-2022 (%)

Exhibit 11: Five forces analysis 2017

Exhibit 12: Five forces analysis 2022

Exhibit 13: Bargaining power of buyers

Exhibit 14: Bargaining power of suppliers

Exhibit 15: Threat of new entrants

Exhibit 16: Threat of substitutes

Exhibit 17: Threat of rivalry

Exhibit 18: Market condition - Five forces 2017

Exhibit 19: Global dermatological drugs market by product – Market share 2017-2022 (%)

Exhibit 20: Comparison by product

Exhibit 21: Global dermatological drugs market by biologics – Market size and forecast 2017-2022 ($ bn)

Exhibit 22: Global dermatological drugs market by biologics – Year over year growth 2018-2022 (%)

Exhibit 23: Global dermatological drugs market by small molecules – Market size and forecast 2017-2022 ($ bn)

Exhibit 24: Global dermatological drugs market by small molecules – Year over year growth 2018-2022 (%)

Exhibit 25: Market opportunity by product

Exhibit 26: Customer landscape

Exhibit 27: Global dermatological drugs market by region – Market share 2017-2022 (%)

Exhibit 28: Regional comparison

Exhibit 29: Dermatological drugs market in Americas – Market size and forecast 2017-2022 ($ bn)

Exhibit 30: Dermatological drugs market in Americas – Year over year growth 2018-2022 (%)

Exhibit 31: Top three countries in Americas

Exhibit 32: Dermatological drugs market in EMEA – Market size and forecast 2017-2022 ($ bn)

Exhibit 33: Dermatological drugs market in EMEA – Year over year growth 2018-2022 (%)

Exhibit 34: Top three countries in EMEA

Exhibit 35: Dermatological drugs market in APAC – Market size and forecast 2017-2022 ($ bn)

Exhibit 36: Dermatological drugs market in APAC – Year over year growth 2018-2022 (%)

Exhibit 37: Top three countries in APAC

Exhibit 38: Market opportunity

Exhibit 39: Vendor landscape

Exhibit 40: Landscape disruption

Exhibit 41: Vendors covered

Exhibit 42: Vendor classification

Exhibit 43: Market positioning of vendors

Exhibit 44: AbbVie overview

Exhibit 45: AbbVie – Business segments

Exhibit 46: AbbVie – Organizational developments

Exhibit 47: AbbVie – Geographic focus

Exhibit 48: AbbVie – Key offerings

Exhibit 49: Amgen overview

Exhibit 50: Amgen – Business segments

Exhibit 51: Amgen – Organizational developments

Exhibit 52: Amgen – Geographic focus

Exhibit 53: Amgen – Key offerings

Exhibit 54: Celgene overview

Exhibit 55: Celgene – Business segments

Exhibit 56: Celgene – Organizational developments

Exhibit 57: Celgene – Geographic focus

Exhibit 58: Celgene – Key offerings

Exhibit 59: Johnson & Johnson overview

Exhibit 60: Johnson & Johnson – Business segments

Exhibit 61: Johnson & Johnson – Organizational developments

Exhibit 62: Johnson & Johnson – Geographic focus

Exhibit 63: Johnson & Johnson – Segment focus

Exhibit 64: Johnson & Johnson – Key offerings

Research Methodology

The research study released with title "Global Dermatological Drugs Market 2018-2022" involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Key Executives Interviewed

Research Programs/Design

Historical Data (2017-2022E)	Industry Trends Competition Analysis & Landscape By Company Product Launches Joint Venture & Partnerships Merger & Acquisitions Market Segment by Type by Application / End Users By Regions/ Geography	Value in Dollar Term Segment Revenue for Major & Emerging Players Market Share % Growth Rate Current Scenario Analysis Sales Volume by Key Players % Market Share & Position % Growth Rate
Market Factor Analysis	Market Environment Government Policy & Regulatory Factors Technological Changes Market Risks & Challenges	Market Drivers Market Maturity Indicators Impact of Cost Variance Growth Determinants
Market Forecast (2023F-2028F)	Overall Size (Value & Volume*) by Type by Application By Region / Country	Key Data (Value & Volume*) %Market Share %Growth Rate CAGR (2023-2028)

Market Size Estimation

Top-down and bottom-up approaches are used to validate and estimate the global/regional market size by manufacturers, regional splits, product segments and application.

To establish Research coverage of the study with most relevant & functional players HTF MI follows industry standards such as NAICS/SIC/ICB/TRCB, furthermore the sorted list of companies is validated using Product Mapping and business activities and shortlisted by industry perspective.

HTF MI select experienced analyst and associate that are specialized in the domain for conducting research. They prepare a list of companies by region that helps to understand players penetration rate in the market. This companies are further analyses in what segment or application they serve in our market. The list of product and applications are evaluated for each companies dealing in the Global Dermatological Drugs Market report. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand company’s positioning regarding market value, volume and their market share for regional as well as global. Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Online) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc from Global Dermatological Drugs Market report who then work towards appointment generation.

Primary Data Collection

The primary research is performed by taking the interviews of executives of various companies dealing in the Global Dermatological Drugs Market report as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and relevant list of appointee or target primary respondents; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & In Mail, Community Forums, Open Survey, SurveyMonkey etc.

Secondary Sources

The secondary resources considered in the Global Dermatological Drugs Market report study includes company annual reports, press releases, published articles of organizations and associations, and the survey taken through different mediums such as online website and forums, survey monkey, LinkedIn, etc. In addition, the valuable strategic information obtained from industry association, paid database, and investor presentations are also good tool for information to make appropriate iterative validation are used to modify market models and cross-verify primary research and insights.

Market Breakdown and Data Triangulation

To make market engineering data complete; extensive primary research is conducted to gather information and validate the critical numbers derived to be used for calculations of market statistics; market size estimations; forecasting; breakdown; and data triangulation. Both top-down and bottom-up approaches were applied, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Furthermore qualitative and further quantitative analysis is also done for all the numbers arrived at in the market estimation process to list relevant information in the final deliverable report "Global Dermatological Drugs Market 2018-2022" .

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Research Journals Company Websites White Papers Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases HTF MI Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segment value
Qualitative Analysis	Influencing Trends Market Potential Market Risks and Opportunities Growth Drivers and Constraints Geographical Footprints Government Policies	Company Websites and Press Releases Survey Reports and Paid Databases Annual Reports Industry Associations HTF MI Database

Key Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments	Market Forecast (Value & Volume*) by Application, Type & Region / Country History and Forecast Market Size (Value & Volume) by Application Market Size by Regions, Status & Forecast	Market Share & Growth Rate by Type & Application Value by Key Business Segments % Growth Rate by Segments Growth Rate and Market Share by Regions Market Size Status & Forecast
Total Market	Overall Size, Status & Forecast	Market Size Status & Forecast

Format		Properties
1-User Access	The report is sent in PDF format. The report will be emailed to you.	This is a single user access license, allowing one specific user to access the report.
Site User	The study would be provided in PDF format. The report will be emailed to you.	This is a site license, allowing 1-10 employees within your organisation to access the report.
Enterprise User	The format of deliverable would be PDF and Excel.	This is an enterprise or corporate license, allowing all employees within your organisation irrespective of geographic location to access the report.